These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 10619926)

  • 1. A qualitative and quantitative analysis of protein substitution in human burn wounds.
    Joneidi-Jafari H; Daigeler A; Hauser J; Steinau HU; Klatte W; Fischer U; Lehnhardt M
    Eplasty; 2009 Sep; 9():e42. PubMed ID: 19865469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial.
    Mortier A; Khoudary J; van Dooslaer de Ten Ryen S; Lannoy C; Benoit N; Antoine N; Copine S; Van Remoortel H; Vandekerckhove P; Compernolle V; Deldicque L
    Vox Sang; 2024 Feb; 119(2):134-143. PubMed ID: 37997609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease].
    Boada-Rovira M
    Rev Neurol; 2010 Mar; 50 Suppl 5():S9-18. PubMed ID: 20517868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange.
    McLeod BC
    Best Pract Res Clin Haematol; 2006; 19(1):157-67. PubMed ID: 16377548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study.
    Boada M; Kiprov D; Anaya F; López OL; Núñez L; Olazarán J; Lima J; Grifols C; Barceló M; Rohe R; Prieto-Fernández C; Szczepiorkowski ZM; Páez A
    J Clin Apher; 2023 Feb; 38(1):45-54. PubMed ID: 36305459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used.
    Kohli R; Geneen LJ; Brunskill SJ; Doree C; Estcourt L; Chee SEJ; Al-Bader R; Sin WYC; MacCallum P; Green L
    J Clin Apher; 2022 Oct; 37(5):438-448. PubMed ID: 35726507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urgent therapeutic plasma exchange.
    Saheb S; Gallo A
    Transfus Apher Sci; 2020 Dec; 59(6):102991. PubMed ID: 33221122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double filtration plasmapheresis in a patient with autoimmune hepatitis-systemic lupus erythematosus overlap.
    Suzuki K; Matsuki Y; Hidaka T; Kawaguchi Y; Kawakami M; Hino K; Nakamura H
    Intern Med; 1993 Sep; 32(9):725-9. PubMed ID: 8142679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
    Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
    Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications of plasmapheresis and selection of different substitution solutions.
    Bambauer R; Jutzler GA; Albrecht D; Keller HE; Kohler M
    Biomater Artif Cells Artif Organs; 1989; 17(1):9-26. PubMed ID: 2775871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmapheresis in autoimmune syndromes. Indications. Results].
    Schooneman F; Gérard A
    Nouv Presse Med; 1982 Dec; 11(52):3847-51. PubMed ID: 6761647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
    Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
    J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases.
    Bambauer R; Arnold A
    Artif Organs; 1999 Dec; 23(12):1079-87. PubMed ID: 10619926
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.